Fischer H J, Schuster H, Keller C, Wolfram G, Zöllner N
Medizinische Poliklinik München.
Klin Wochenschr. 1991 Nov 15;69(18):842-6. doi: 10.1007/BF01649457.
In a large family with clinical characteristics of heterozygous familial hypercholesterolemia (FH) seven restriction fragment length polymorphisms (RFLP) were used to determine low-density-lipoprotein receptor (LDLR) gene haplotypes. Following the inheritance of the LDL receptor genes characterized by their seven RFLP haplotypes, two different alleles were found to cosegregate with elevated cholesterol levels within this family. In a 76-year-old man both alleles identified as defective were present, thus classifying this individual as heterozygous compound for FH. In five heterozygous family members one allele was associated with 38% higher cholesterol levels when compared to the other mutant allele in two heterozygous family members. Cosegregation of hypercholesterolemia with the apolipoprotein B (apoB) gene and apolipoprotein E (apoE) gene was excluded by genotyping all individuals for the apoB XbaI RFLP and apoE polymorphisms. These findings are consistent with variable phenotypic expression of the mutant LDLR gene alleles.
在一个具有杂合子家族性高胆固醇血症(FH)临床特征的大家庭中,使用了7种限制性片段长度多态性(RFLP)来确定低密度脂蛋白受体(LDLR)基因单倍型。通过其7种RFLP单倍型对LDL受体基因的遗传情况进行追踪后,发现该家族中有两个不同的等位基因与胆固醇水平升高共分离。在一名76岁男性中,两个被鉴定为有缺陷的等位基因均存在,因此将该个体归类为FH杂合子复合突变型。在5名杂合子家族成员中,与另外两名杂合子家族成员中的另一个突变等位基因相比,一个等位基因与高38%的胆固醇水平相关。通过对所有个体进行载脂蛋白B(apoB)基因XbaI RFLP和载脂蛋白E(apoE)基因多态性基因分型,排除了高胆固醇血症与apoB基因和apoE基因的共分离。这些发现与突变型LDLR基因等位基因的可变表型表达一致。